Page last updated: 2024-08-25

rosiglitazone and Malaria, Falciparum

rosiglitazone has been researched along with Malaria, Falciparum in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayi, K; Gowda, DC; Kain, KC; Liles, WC; Lu, Z; Patel, SN; Serghides, L1
Boggild, AK; Kain, KC; Katz, K; Krudsood, S; Liles, WC; Looareesuwan, S; Patel, SN; Serghides, L; Tangpukdee, N; Wilairatana, P1
John, CC; Kutamba, E; Mugarura, K; Opoka, RO1
Higgins, SJ; Kain, KC; Liles, WC1

Reviews

2 review(s) available for rosiglitazone and Malaria, Falciparum

ArticleYear
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
    Expert review of anti-infective therapy, 2010, Volume: 8, Issue:9

    Topics: Antimalarials; Arginine; Erythropoietin; Humans; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones

2010
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:9

    Topics: Africa; Antimalarials; Arginine; Clinical Trials as Topic; Dexamethasone; Epidemiologic Studies; Erythropoietin; Humans; Immunomodulation; Inflammation; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Nitric Oxide; Plasmodium falciparum; PPAR gamma; Rosiglitazone; Thiazolidinediones

2011

Trials

1 trial(s) available for rosiglitazone and Malaria, Falciparum

ArticleYear
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Sep-15, Volume: 49, Issue:6

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult

2009

Other Studies

1 other study(ies) available for rosiglitazone and Malaria, Falciparum

ArticleYear
Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria.
    The Journal of infectious diseases, 2009, May-15, Volume: 199, Issue:10

    Topics: Animals; CD36 Antigens; Flow Cytometry; Humans; Immunity, Innate; Leukocytes, Mononuclear; Macrophages; Malaria, Cerebral; Malaria, Falciparum; Mice; Phagocytosis; Plasmodium falciparum; Rosiglitazone; Signal Transduction; Survivors; Thiazolidinediones

2009